Zhejiang Hisun Pharmaceutical Co., Ltd. (600267.SS)
CNY 8.44
(0.12%)
CNY 8.44
(0.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.37 Billion | 12.03 Billion | 12.13 Billion | 11.35 Billion | 11.07 Billion | 10.18 Billion |
| Cost of Revenue | 6.18 Billion | 6.99 Billion | 7.18 Billion | 6.44 Billion | 6.31 Billion | 5.93 Billion |
| Gross Profit | 4.18 Billion | 5.03 Billion | 4.94 Billion | 4.91 Billion | 4.75 Billion | 4.25 Billion |
| Operating Expenses | 3.96 Billion | 3.87 Billion | 3.85 Billion | 3.72 Billion | 4.62 Billion | 3.84 Billion |
| Selling, General and Administrative Expenses | 2.53 Billion | 2.67 Billion | 2.71 Billion | 2.74 Billion | 3.12 Billion | 2.77 Billion |
| Research and Development Expenses | 391.95 Million | 428.69 Million | 372.79 Million | 401.14 Million | 903.81 Million | 639.52 Million |
| Other Expenses | 290.42 Million | 775.63 Million | 769.17 Million | 579.95 Million | 596.31 Million | -9.15 Million |
| Cost and Expenses | 10.28 Billion | 10.87 Billion | 11.04 Billion | 10.16 Billion | 10.94 Billion | 9.77 Billion |
| Operating Income | 89.44 Million | 1.1 Billion | 1.15 Billion | 1.36 Billion | 2.65 Billion | -102.98 Million |
| Interest Expense | 215.4 Million | 283.12 Million | 345.8 Million | 420.74 Million | 525.67 Million | 401.67 Million |
| Income Tax Expense | 14.14 Million | 192 Million | 133.56 Million | 180.97 Million | 183.82 Million | 124.62 Million |
| Earnings before Tax | -82.86 Million | 683.42 Million | 644.19 Million | 904.14 Million | 507.09 Million | -112.34 Million |
| Net Income | -93.17 Million | 488.86 Million | 486.88 Million | 723.16 Million | 323.26 Million | -492.47 Million |
| Earnings Per Share Basic | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 |
| Earnings Per Share Diluted | -0.08 | 0.42 | 0.43 | 0.75 | 0.33 | -0.51 |
| Weighted Average Shares Outstanding | 1.16 Billion | 1.15 Billion | 1.13 Billion | 965.53 Million | 965.53 Million | 965.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.15 Billion | 1.13 Billion | 965.53 Million | 965.53 Million | 965.63 Million |
| Gross Margin | 0.40 | 0.42 | 0.41 | 0.43 | 0.43 | 0.42 |
| EBIT Margin | 0.11 | 0.18 | 0.17 | 0.20 | 0.32 | 0.12 |
| Profit Margin | -0.01 | 0.04 | 0.04 | 0.06 | 0.03 | -0.05 |
| EBITDA | 1.18 Billion | 2 Billion | 1.94 Billion | 2.19 Billion | 1.92 Billion | 1.02 Billion |
| Earnings Before Tax Margin | 0.01 | 0.09 | 0.10 | 0.12 | 0.24 | -0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.63 Billion | 2.49 Billion | 2.72 Billion | 1.67 Billion | 10.37 Billion | 2.64 Billion |
| Cost of Revenue | 1.45 Billion | 1.54 Billion | 1.74 Billion | 1.08 Billion | 6.18 Billion | 1.56 Billion |
| Gross Profit | 1.17 Billion | 950.73 Million | 985.79 Million | 590.9 Million | 4.18 Billion | 1.07 Billion |
| Operating Expenses | 920.05 Million | 787.35 Million | 763.07 Million | 853.23 Million | 3.63 Billion | 921.3 Million |
| Selling, General and Administrative Expenses | 1.59 Billion | 680.75 Million | 683.15 Million | 45.86 Million | - | 1.15 Billion |
| Research and Development Expenses | 85.08 Million | 66.12 Million | 89.18 Million | 80.57 Million | - | 101.22 Million |
| Other Expenses | -755.58 Million | -40.46 Million | -2.29 Million | -124.03 Million | -172.3 Million | -1.81 Million |
| Cost and Expenses | 2.37 Billion | 2.33 Billion | 2.5 Billion | 1.93 Billion | 9.82 Billion | 2.48 Billion |
| Operating Income | 118.35 Million | 163.38 Million | 272.88 Million | -522.21 Million | 89.44 Million | 78.81 Million |
| Interest Expense | 35.76 Million | 40.68 Million | 46.82 Million | 48.79 Million | 215.4 Million | 52.1 Million |
| Income Tax Expense | 43.7 Million | 27.29 Million | 24.23 Million | -91.04 Million | 14.14 Million | 35.48 Million |
| Earnings before Tax | 119.95 Million | 208.81 Million | 270.58 Million | -646.25 Million | -82.86 Million | 77.29 Million |
| Net Income | 80.07 Million | 186.71 Million | 248.53 Million | -535.55 Million | -93.17 Million | 38.24 Million |
| Earnings Per Share Basic | 0.07 | 0.16 | 0.21 | -0.46 | - | 0.03 |
| Earnings Per Share Diluted | 0.07 | 0.16 | 0.21 | -0.46 | - | 0.03 |
| Weighted Average Shares Outstanding | 1.16 Billion | 1.16 Billion | 1.18 Billion | 1.15 Billion | 1.16 Billion | 1.13 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.16 Billion | 1.16 Billion | 1.18 Billion | 1.15 Billion | 1.16 Billion | 1.13 Billion |
| Gross Margin | 0.45 | 0.38 | 0.36 | 0.35 | 0.40 | 0.41 |
| EBIT Margin | 0.06 | 0.17 | 0.13 | -0.23 | - | 0.05 |
| Profit Margin | 0.03 | 0.07 | 0.09 | -0.32 | -0.01 | 0.01 |
| EBITDA | 155.71 Million | 436.32 Million | 351.91 Million | -386.28 Million | - | 130.84 Million |
| Earnings Before Tax Margin | 0.04 | 0.07 | 0.10 | -0.31 | 0.01 | 0.03 |
0292
4DS
601328
KFR
FMBL
AZO